Company: CRNX
Filing Date: 2025-05-20
Form Type: DEFA14A
Source: 0000950170-25-074707
Chunk: 1

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-05-20
Form: DEFA14A
Chunk 1
---
 Statement as “Friday” instead of “Wednesday.” For the avoidance of doubt, the Annual Meeting will be held on Wednesday, June 11, 2025, at 8:00 a.m. Pacific Time.

The Annual Meeting was incorrectly identified on page 1 of the Proxy Statement as the “2024 Annual Meeting” instead of the “2025 Annual Meeting.”

The last sentence under the heading “Stockholder Proposals” on page 62 of the Proxy Statement incorrectly stated the deadline for stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees at the Company’s 2026 annual meeting of stockholders to provide notice pursuant to Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as “April 12, 2025” instead of “April 13, 2026.” For the avoidance of doubt, in addition to satisfying the requirements under the Company’s amended and restated bylaws, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees at the Company’s 2026 annual meeting of stockholders must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than April 13, 2026.

Except as specifically updated by the information contained above, all information set forth in the Proxy Statement remains unchanged.

<div align='center'>***</div>

This Supplement is being filed with the SEC, and first made available to shareholders on, May 19, 2025. No other changes have been made to the Proxy Statement or to the matters to be considered at the Annual Meeting, and this Supplement does not otherwise modify or affect the Proxy Statement. If you have already voted your shares, you do not need to vote again unless you wish to change your vote on any proposal.